M. Pauliina Margolis
Technik-/Wissenschafts-/F&E-Leiter bei Keystone Heart Ltd.
Profil
M.
Pauliina Margolis is currently the Chief Medical Officer & Vice President at Keystone Heart Ltd.
She previously worked as the VP-Scientific Affairs & Medical Director at Philips Image Guided Therapy Corp.
She obtained a doctorate degree from the University of Cincinnati (Ohio).
Aktive Positionen von M. Pauliina Margolis
| Unternehmen | Position | Beginn |
|---|---|---|
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 25.04.2012 |
Ehemalige bekannte Positionen von M. Pauliina Margolis
| Unternehmen | Position | Ende |
|---|---|---|
| VOLCANO CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von M. Pauliina Margolis
| University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Philips Image Guided Therapy Corp.
 Philips Image Guided Therapy Corp. Medical SpecialtiesHealth Technology Volcano Corp. designs, develops and manufactures a broad suite of intravascular ultrasound products. The company was founded by Olav B. Bergheim and Samuel Ward Casscells and is headquartered in San Diego, CA. | Health Technology |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Health Technology |